Reducing Frailty for Older Cancer Survivors Using Supplements II

NCT06068543 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Frailty
Inflammation

Interventions

DRUG: Epigallocatechin-3-Gallate (EGCG)
DRUG: Microcrystalline cellulose (MCC)
DIETARY_SUPPLEMENT: Ascorbic Acid (Vitamin C)

Sponsor

University of Rochester